Gender differences in depression and antidepressant pharmacokinetics and adverse events

Annals of Pharmacotherapy

Volumn 34, Issue 1, 2000, Pages 80-88

  Frackiewicz, Edyta J ^a   Sramek, John J ^a   Cutler, Neal R ^a  

^a CALIFORNIA CLINICAL TRIALS   (United States)

Author keywords

Antidepressants; Depression; Women

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; IMIPRAMINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; AGED; BIOLOGY; CONTROLLED STUDY; DEPRESSION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG RESPONSE; FEMALE; GENDER; HUMAN; MALE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SEXUAL DYSFUNCTION; SOCIAL ASPECT; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; SEX CHARACTERISTICS;

EID: 0033955194     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18465     Document Type: Review

References (124)

1. Halbreich U, Lumley LA. The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord 1993;29:159-73.
2. Moody JP, Tait AC, Todrick A. Plasma levels of imipramine and desmethylimipramine during therapy. Br J Psychiatry 1967;113:183-93.
3. Glassman AH, Perel JM, Shostak M, Kantor SS, Fleiss JL. Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 1977;34:197-204.
4. Preskorn SH, Mac DS. Plasma levels of amitriptyline: effect of age and sex. J Clin Psychiatry 1985;46:276-7.
5. Greenblatt DJ, Friedman H, Burstein ES, Scavone JM, Blyden GT, Ochs HR, et al. Trazodone kinetics: effects of age, gender, and obesity. Clin Pharmacol Ther 1987;42:193-200.
6. Gex-Fabry M, Balant-Gorgia AE, Balant LP, Garrone G. Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data. Clin Pharmacokinet 1990;19:241-55.
7. Barbhaiya RH, Buch AB, Greene DS. A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses. J Clin Psychopharmacol 1996;16:19-25.
8. Dahl M, Bertilsson L, Nordin C. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype. Psychopharmacology (Berl) 1996;123:315-9.
9. Klamerus KJ, Parker VD, Rudolph RL, Derivan AT, Chiang ST. Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokinetics. Pharmacotherapy 1996;16:915-23.
10. Ronfeld RA, Tremaine LM, Wilner KD. Pharmacokinetics of sertraline and its N-desmethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet 1997;32(suppl 1):22-30.
11. Kornstein SG. Gender differences in depression: implications for treatment. J Clin Psychiatry 1997;58(suppl 15):S12-8.
12. Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;34:98-111.
13. Ernst C, Angst J. The Zurich study, XII. Sex differences in depression. Evidence from longitudinal epidemiological data. Eur Arch Psychiatry Clin Neurosci 1992;241:222-30.
14. Kornstein SG, Schatzberg AF, Yonkers KA, Thase ME, Keitner GI, Ryan CE, et al. Gender differences in presentation of chronic major depression. Psychopharmacol Bull 1995;31:711-8.
15. Roy A. Suicide. In: Kaplan HI, Sadock BJ, eds. Comprehensive textbook of psychiatry. 6th ed. Baltimore: Williams & Williams, 1995:1739-51.
16. Hamilton JA, Grant M, Jensvold MF. Sex and treatment of depression: when does it matter? In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and women. Washington, DC: American Psychiatric Press, 1996:241-57.
17. Frank E, Carpenter LL, Kupfer DJ. Sex differences in recurrent depression: are there any that are significant? Am J Psychiatry 1988;145:41-5.
18. Young MA, Scheftner WA, Fawcett J, Klerman GL. Gender differences in the clinical features of unipolar major depressive disorder. J Nerv Ment Dis 1990;178:200-3.
19. Suris JC, Parera N, Puig C. Chronic illness and emotional distress in adolescence. J Adolesc Health 1996;19:153-6.
20. Gove WR, Tudor JF. Adult sex roles and mental illness. Am J Soc l973;78:812-35.
21. Nolen-Hoeksema S. Sex differences in unipolar depression: evidence and theory. Psychol Bull 1987;101:259-82.
22. Pugliesi K. Women and mental health: two traditions of feminist research. Women Health 1992;19:43-68.
23. Radloff LS. Sex differences in depression: the effects of occupation and marital status. Sex Roles 1975;1:249-65.
24. Harris T, Surtees P, Bancroft J. Is sex necessarily a risk factor to depression? BrJ Psychiatry 1991;158:708-12.
25. Almqvist F. Sex differences in adolescent psychopathology. Acta Psychiatr Scand 1986;73:295-306.
26. Greenley JR, Mechanic D, Cleary PD. Seeking help for psychologic problems. A replication and extension. Med Care 1987;25:1113-28.
27. Horgan CM. Specialty and general ambulatory mental health services. Comparison of utilization and expenditures. Arch Gen Psychiatry 1985; 42:565-72.
28. Wells KB, Manning WG, Duan N, Newhouse JP, Ware JE Jr. Sociodemographic factors, and the use of outpatient mental health services. Med Care 1986;24:75-85.
29. Kessler RC, Brown RL, Broman CL. Sex differences in psychiatric help-seeking: evidence from four large-scale surveys. J Health Soc Behav 1981;22:49-64.
30. Leaf PJ, Bruce ML. Gender differences in the use of mental health-related services: a re-examination. J Health Soc Behav 1987;28:171-83.
31. Williams JB, Spitzer RL. The issue of sex bias in DSM-III. A critique of "A Woman's View of DSM-III" by Marcie Kaplan. Am Psychol 1983; 38:793-8.
32. Balter MB, Levine J, Manheimer DI. Cross-national study of the extent of anti-anxiety-sedative drug use. N Engl J Med 1974;290:769-74.
33. Cafferata GL, Kasper J, Bernstein A. Family roles, structure, and stressors in relation to sex differences in obtaining psychotropic drugs. J Health Soc Behav 1983;24:132-43.
34. Cooperstock R. Sex differences in the use of mood-modifying drugs: an explanatory model. J Health Soc Behav 1971;12:238-44.
35. Cooperstock R. A review of women's psychotropic drug use. Can J Psychiatry 1979;24:29-34.
36. Mant A, Broom DH, Duncan-Jones P. The path to prescription: sex differences in psychotropic drug prescribing for general practice patients. Soc Psychiatry 1983;18:185-92.
37. Trinkoff AM, Anthony JC, Munoz A. Predictors of the initiation of psychotherapeutic medicine use. Am J Public Health 1990;80:61-5.
38. Padgett DK. Women's mental health: some directions for research. Am J Orthopsychiatry 1997;67:522-34.
39. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994.
40. Chiovato L, Lapi P, Fiore E, Tonacchera M, Pinchera A. Thyroid autoimmunity and female gender. J Endocrinol Invest 1993;16:384-91.
41. Lahita RG. The connective tissue diseases and the overall influence of gender. Int J Fertil Menopausal Stud 1996;41:156-65.
42. Lash AA. Why so many women? Part 1. Systemic lupus erythematosus. Medsurg Nurs 1993;2:259-64
43. McCarty DJ, Maazi S, Medsger TA, Ramsey-Goldman R, La Porte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender difference. Arthritis Rheum 1995;38:1260-70.
44. Nolen-Hoeksema S, Girgus JS. The emergence of gender differences in depression during adolescence. Psychol Bull 1994;115:424-43.
45. McGee R, Feehan M, Williams S, Anderson J. DSM-III disorders from age 11 to 15 years. J Am Acad Child Adolesc Psychiatry 1992;31:50-9.
46. Wichstrom L. The emergence of gender difference in depressed mood during adolescence: the role of intensified gender socialization. Dev Psychol 1999;35:232-45.
47. Angold A, Worthman CW. Puberty onset of gender differences in rates of depression: a developmental, epidemiologic and neuroendocrine perspective. J Affect Disord 1993;29:145-58.
48. Guyer B, Lescohier I, Gallagher SS, Hausman A, Azzara CV. Intentional injuries among children and adolescents in Massachusetts. N Engl J Med 1989;321:1584-9.
49. Velez, CN, Johnson J, Cohen P. A longitudinal analysis of selected risk factors for childhood psychopathology. J Am Acad Child Adolesc Psychiatry 1989;28:861-4.
50. McGee R, Feehan M, Williams S, Partridge F, Silva PA, Kelly J. DSM-III disorders in a large sample of adolescents. J Am Acad Child Adolesc Psychiatry 1990;29:611-9.
51. Rutter M, Graham P, Chadwick OF, Yule W. Adolescent turmoil: fact or fiction? J Child Psychol Psychiatry 1976;17:35-56.
52. Seeman MV. Psychopathology in women and men; focus on female hormones. Am J Psychiatry 1997;154:1641-7.
53. Hushani BA, Moore ST, Castor RS, Neser W, Whitten-Stoval R, Linn JG, et al. Social density, stressors and depression: gender differences among the black elderly. J Gerontol 1991;46:236-42.
54. Ruble DN, Greulich F, Pomerantz EM, Gochberg B. The role of gender-related processes in the development of sex differences in self-evaluation and depression. J Affect Disord 1993;29:97-128.
55. Veijola J, Puukka P, Lehtinen V, Moring J, Lindholm T, Vaisanen E. Sex differences in the association between childhood experiences and adult depression. Psychol Med 1998;28:21-7.
56. Browne A. Family violence and homelessness: the relevance of trauma histories in the lives of homeless women. Am J Orthopsychiatry 1993; 63:370-84.
57. Davidson, LL. Preventing injuries from violence towards women (editorial). Am J Public Health 1996;86:12-4.
58. Schafran LH. Rape is a major public health issue. Am J Public Health 1996;86:15-7.
59. Sorenson SB, Upchurch DM, Shen H. Violence and injury in marital arguments: risk patterns and gender differences. Am J Public Health 1996; 86:35-40.
60. Finkelhor D, Browne A. The traumatic impact of child sexual abuse: a conceptualization. Am J Orthopsychiatry 1985;55:530-41.
61. Mirowsky J, Ross C. Sex differences in distress: real or artifact? Am Sociological Rev 1995;60:449-68.
62. Trickett PK, Putnam FW. Impact of child sexual abuse on females: toward a developmental psychobiological integration. Psychol Sci 1993;4: 81-7.
63. Belle D. Poverty and women's mental health. Am Psychol 1990;45:385-9.
64. McLanahan SS, Sorensen A, Watson D. Sex differences in poverty, 1950-1980. Signs: A Journal of Women in Culture and Society 1989;15: 102-44.
65. Gove W, Herb T. Stress and mental illness among the young: a comparison of the sexes. Soc Forces 1974;53:256-65.
66. Kisekka MN. Gender and mental health in Africa. In: Rothblum ED, Cole E, eds. Women's mental health in Africa. New York: Haworth Press, 1990:1-13.
67. Kendler KS, Prescott CA. A population-based twin study of lifetime major depression in men and women. Arch Gen Psychiatry 1999;56:39-44.
68. Buchanan CM, Eccles J, Becker J. Are adolescents the victims of raging hormones? Evidence for activational effects on hormones on moods and behavioral adolescence. Psychol Bull 1992;111:62-107.
69. Ruble DN, Greulich F, Pomerantz EM, Gochberg B. The role of gender-related processes in the development of sex differences in self-evaluation and depression. J Affect Disord 1993;29:97-128.
70. Brooks-Gunn J, Ruble DN. Dysmenorrhea in adolescence. In: Golub S, ed. Menarche. Lexington, MA: Lexington Books, 1983:251-62.
71. Angold A, Rutter M. Effects of age and pubertal status on depression in a large clinical sample. Dev Psychopathol 1992;4:5-28.
72. Crockett LJ, Petersen AC. Pubertal status and psychosocial development: findings from the early adolescence study. In: Lerner RM, Foch TT, eds. Biological psychosocial interaction in early adolescence. Hillsdale, NJ: Erlbaum, 1987:173-88.
73. Brooks-Gunn J, Warren MP. Biological and social contributions to negative affect in young adolescent girls. Child Dev 1989;60:40-55.
74. Joffe H, Cohen LS. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry 1998;44:798-811.
75. McEwen BS. Nongenomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991;12:141-7.
76. O'Malley BW, Means AR. Female steroid hormone and target cell nuclei. Science 1974;183:610-20.
77. Sherwin BB, Suranyi-Cadotte BE. Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry 1990;28:339-48.
78. Carlsson M, Carlsson A. A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:53-61.
79. Pearlstein TB. Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 1995;173:646-53.
80. Luine VN, Rhodes JC. Gonadal hormone regulation of MAO and other enzymes in hypothalamic areas. Neuroendocrinology 1983;36:235-41.
81. Bebbington PE, Dunn G, Jenkins R, Lewis G, Brugha T, Farrell M, et al. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Psychol Med 1998;328:9-19.
82. Robins LN, Rigier DA. Psychiatric disorders in America: the Epidemiological Catchment Area Study. New York: Free Press, 1991.
83. Bland RD, Orn H, Newman SC. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 1988;77:24-32.
84. Steward DE, Boydell KM. Psychologic distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 1993;23:157-62.
85. Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br J Psychiatry 1994;164:513-6.
86. Parry BL. Reproductive factors affecting the course of affective illness. Psychiatr Clin North Am 1989;12:207-20.
87. Rubinow DR, Hoban MC, Graver GN, Galloway DS, Roy-Byrne P, Andersen R, et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually-related mood disorder and in control subjects. Am J Obstet Gynecol 1988;158:5-11.
88. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1988;338:209-16.
89. Rubinow DR. The premenstrual syndrome: new views. JAMA 1992; 268:1908-12.
90. Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. Br J Psychiatry 1984;144:35-47.
91. Dam H, Mellerup ET. Winter depression and light therapy. Ugeskr Laeger 1994;156:5994-8.
92. Leibenluft E, Hardin TA, Rosenthal NE. Gender differences in seasonal affective disorder. Depression 1995;3:313-9.
93. Leibenluft E. Do gonadal steroids regulate circadian rhythms in humans? J Affect Disord 1993;29:175-81.
94. Partonen T. Estrogen could control photoperiodic adjustment in seasonal affective disorder. Med Hypotheses 1995;45:35-6.
95. Brooks-Gunn J. Antecedents and consequences of variations in girls' maturational timing. J Adolesc Health Care 1988;9:365-73.
96. Greif EB, Ulman KJ. The psychological impact of menarche on early adolescent females: a review of the literature. Child Dev 1982;53:1413-30.
97. Wichstrom L. The emergence of gender difference in depressed mood during adolescence: the role of intensified gender socialization. Dev Psychol 1999;35:232-15.
98. Dornbusch SM, Carlsmith JM, Duncan PD, Gross RT, Martin JA, Ritter PL, et al. Sexual maturation, social class, and the desire to be thin among adolescent females. J Dev Behav Pediatr 1984;5:308-14.
99. McCarthy M. The thin ideal: depression and eating disorders in women. Behav Res Ther 1990;28:205-15.
100. Hamilton JA, Jensvold MF. Sex and gender as critical variables in feminist psychopharmacology research and pharmacotherapy. Women Therapy 1995;16:9-30.
101. Yonkers KA, Kando JC, Cole JO, Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992;149:587-95.
102. Wald A, Van Thiel DH, Hoechstetter L, Egler KM, Verm R, Scott L, et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981;80:1497-500.
103. Hudson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989;96:11-7.
104. Wisner KL, Perel JM, Wheeler SB. Tricyclic dose requirements across pregnancy. Am J Psychiatry 1993;150:1541-2.
105. Sutfin TA, Perini GI, Molan G, Jusko WJ. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients. J Clin Psychopharmacol 1988;8:48-53.
106. Perel JM, Mendlewicz J, Shostak M, Kantor SJ, Glassman AH. Plasma levels of imipramine in depression. Environmental and genetic factors. Neuropsychobiology 1976;2:193-202.
107. Jusko WJ. Role of tobacco smoking in pharmacokinetics. J Pharmacokinet Biopharm 1978;6:7-39.
108. Lane EA, Guthrie S, Linniola M. Effects of ethanol on drugs and metabolite pharmacokinetics. Clin Pharmacokinet 1985;10:228-47.
109. Muhoberac BB, Roberts RK, Hoympa AM, Schenker S. Mechanism(s) of ethanol-drug interaction. Alcohol Clin Exp Res 1984;8:583-93.
110. Abernethy DR, Greenblatt DJ, Shader RI. Imipramine disposition in users of oral contraceptive steroids. Clin Pharmacol Ther 1984;35:792-7.
111. Mitani GM, Steinberg I, Lien EJ, Harrison EC, Elkayam U. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation. Clin Pharmacokinet 1987;12:253-91.
112. Baron TH, Ramirez B, Richter JE. Gastrointestinal motility disorders during pregnancy. Ann Intern Med 1993;118:366-75.
113. Everson GT. Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am 1992;21:751-76.
114. Guay J, Grenier Y, Vann F. Clinical pharmacokinetics of neuromuscular relaxants in pregnancy. Clin Pharmacokinet 1998;34:483-96.
115. Dawkins K, Potter WZ. Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women. Psychopharmacol Bull 1991:27:417-26.
116. Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients. Int J Psychiatry Med 1995;25:239-48.
117. Feiger A, Kiev A, Shrivastava RK, Wisselnik PG, Wilcox CS. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57:53-62.
118. Amsterdam JD, Garcia-Espana F, Goodman D, Hooper M, Homig-Rohan M. Breast enlargement during chronic antidepressant therapy. J Affect Disord 1997;46:151-6.
119. Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, et al. Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. Am J Psychiatry 1997;154:1757-65.
120. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999;9:67-85.
121. Gardner EA, Johnston JA. Buproprion: an antidepressant without sexual psychophysiological action. J Clin Psychopharmacol 1985;5:24-9.
122. Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Baley SR, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to buproprion. J Clin Psychiatry 1993;54:459-65.
123. La Rosa JH, Pinn VW. Gender bias in biomedical research. J Am Med Women's Assoc 1993;48:145-51.
124. Kinney EL, Trautmann J, Gold JA, Vesell ES, Zelis R. Underrepresentation of women in new drug trials: ramification and remedies. Ann Intern Med 1981;95:495-9.